Highlights 514 blood samples collected for CLEO’s clinical trial, representing a key step toward the Company’s FDA submission for its Pre-Surgical Ovarian Cancer Test 624 women enrolled across 19 U.S. sites, demonstrating strong trial execution supporting a robust final study dataset Binding manufacturing agreement for test kit production remains in the final stages following recent biomarker panel ... Continued